1. Gemcitabine sensitizes lung cancer cells to Fas/FasL system‐mediated killing. Issue 2 (February 2014) Authors: Siena, Liboria; Pace, Elisabetta; Ferraro, Maria; Di Sano, Caterina; Melis, Mario; Profita, Mirella; Spatafora, Mario; Gjomarkaj, Mark Journal: Immunology Issue: Volume 141:Issue 2(2014:Feb.) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗